ACW XanaMIA trial fully enrolled with 246th participant
Released 17 Dec 25
Latest announcements
Announcement summary
ACW XanaMIA trial fully enrolled with 246th participant
Ask a question
Your question will be sent privately to Actinogen. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Actinogen a question about this announcement.